12 Einträge gefunden

1. Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer

   1. Oliveira-Ferrer, L
   2. Heßling, A
   3. Trillsch, F
   4. Mahner, S
   5. Milde-Langosch, K

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties

   1. Oliveira-Ferrer, Leticia
   2. Kürschner, M
   3. Labitzky, V
   4. Wicklein, D
   5. Müller, V
   6. Lüers, G
   7. Schumacher, U

   2015 - Forschungsinformationssystem des UKE
3. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.

   1. Milde-Langosch, K
   2. Bamberger, A-M
   3. Rieck, G
   4. Grund, D
   5. Hemminger, G
   6. Müller, V
   7. Löning, Thomas

   2005 - Forschungsinformationssystem des UKE
4. PTEN expression in breast and endometrial cancer: correlations with steroid hormone receptor status.

   1. Kappes, H
   2. Goemann, Christoph
   3. Bamberger, A M
   4. Löning, Thomas
   5. Milde-Langosch, K

   2001 - Forschungsinformationssystem des UKE
5. Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.

   1. Milde-Langosch, K
   2. Bamberger, A M
   3. Rieck, G
   4. Kelp, B
   5. Löning, Thomas

   2001 - Forschungsinformationssystem des UKE
6. The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium.

   1. Bamberger, A M
   2. Milde-Langosch, K
   3. Löning, Thomas
   4. Bamberger, C M

   2001 - Forschungsinformationssystem des UKE
7. Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters.

   1. Milde-Langosch, K
   2. Bamberger, A M
   3. Goemann, Christoph
   4. Rössing, E
   5. Rieck, G
   6. Kelp, B
   7. Löning, Thomas

   2001 - Forschungsinformationssystem des UKE
8. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators.

   1. Bamberger, A M
   2. Milde-Langosch, K
   3. Rössing, E
   4. Goemann, Christoph
   5. Löning, Thomas

   2001 - Forschungsinformationssystem des UKE
9. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.

   1. Friedrich, Martin
   2. Blind, C
   3. Milde-Langosch, K
   4. Erbersdobler, A
   5. Conrad, S
   6. Löning, Thomas
   7. Hammerer, P

   2001 - Forschungsinformationssystem des UKE
10. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.

    1. Milde-Langosch, K
    2. Goemann, C
    3. Methner, C
    4. Rieck, G
    5. Bamberger, A M
    6. Löning, T

    2001 - Forschungsinformationssystem des UKE
11. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.

    1. Milde-Langosch, K
    2. Riethdorf, Sabine
    3. Kraus-Pöppinghaus, A
    4. Riethdorf, L
    5. Löning, Thomas

    2001 - Forschungsinformationssystem des UKE
12. Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas

    1. Hagel, C
    2. Laking, G
    3. Laas, R
    4. Scheil, S
    5. Jung, R
    6. Milde-Langosch, K
    7. Stavrou, D K

    1996 - Forschungsinformationssystem des UKE